Next Article in Journal
Activation of Sonic Hedgehog Signaling Promotes Differentiation of Cortical Layer 4 Neurons via Regulation of Their Cell Positioning
Next Article in Special Issue
The Development of the Chimaeroid Pelvic Skeleton and the Evolution of Chondrichthyan Pelvic Fins
Previous Article in Journal
Seeking Sense in the Hox Gene Cluster
Previous Article in Special Issue
The Shape of the Jaw—Zebrafish Col11a1a Regulates Meckel’s Cartilage Morphogenesis and Mineralization
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
JDB
Volume 10
Issue 4
10.3390/jdb10040049
jdb-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Review

Organophosphate Insecticide Toxicity in Neural Development, Cognition, Behaviour and Degeneration: Insights from Zebrafish

by
Jeremy Neylon
,
Jarrad N. Fuller
,
Chris van der Poel
,
Jarrod E. Church
and
Sebastian Dworkin
*
Department of Microbiology, Anatomy, Physiology and Pharmacology, La Trobe University, Melbourne, VIC 3086, Australia
*
Author to whom correspondence should be addressed.
J. Dev. Biol. 2022, 10(4), 49; https://doi.org/10.3390/jdb10040049
Submission received: 5 October 2022 / Revised: 15 November 2022 / Accepted: 16 November 2022 / Published: 21 November 2022
(This article belongs to the Special Issue 2022 Feature Papers by JDB’s Editorial Board Members)
Browse Figures
Review Reports Versions Notes

Abstract

:
Organophosphate (OP) insecticides are used to eliminate agricultural threats posed by insects, through inhibition of the neurotransmitter acetylcholinesterase (AChE). These potent neurotoxins are extremely efficacious in insect elimination, and as such, are the preferred agricultural insecticides worldwide. Despite their efficacy, however, estimates indicate that only 0.1% of organophosphates reach their desired target. Moreover, multiple studies have shown that OP exposure in both humans and animals can lead to aberrations in embryonic development, defects in childhood neurocognition, and substantial contribution to neurodegenerative diseases such as Alzheimer’s and Motor Neurone Disease. Here, we review the current state of knowledge pertaining to organophosphate exposure on both embryonic development and/or subsequent neurological consequences on behaviour, paying particular attention to data gleaned using an excellent animal model, the zebrafish (Danio rerio).

1. The Need for Insecticides

Insecticides are a class of pesticides used to eliminate insects and are employed in areas such as crop development, animal husbandry, agriculture and household environments [1]. On a global scale, insecticides account for 20% of the pesticide market [2], where their widespread use in agriculture improves crop quality and yield, and optimises the revenue and economic yield of harvests [3,4,5]. Additionally, the use of insecticides protects consumers against vector-borne diseases [6,7], forming a crucial front-line defence to safeguard the agricultural sector. However, these pesticides do not only eliminate the insects they target, but, as we will discuss here, also cause significant off-target effects to livestock, aquatic species and humans.
Whilst insects constitute an integral component of terrestrial ecosystems [8,9], their control requires significant expenditure from the agricultural sector. In 2012–2013, usage in Australian agriculture totalled approximately $350 billion on insecticides [10,11], demonstrating the economic burden of pests in agrarian settings. Despite this, the alternative (that is, non-use) is financially unviable owing to the limitless potential for insect-mediated agricultural destruction, indicating that insecticides are necessary to safeguard and maintain food production. With an increasing population and limited agrarian land available, improving production and productivity on existing land is integral for safeguarding long-term food security [12]. Therefore, insect management is critical in commercial agriculture, yet the dangerous neurotoxic activity of the most commonly used insecticides must be strictly modulated, in order to ensure both efficacy and safety to non-insect species.

2. Insecticides—The Move to Organophosphates (OPs)

Among the earliest implementation of synthetic compounds for insecticidal purposes was the development of organochlorine (OC) insecticides, such as dichlorodiphenyl-trichloroethane (DDT), cyclodienes including aldrin, dieldrin, heptachlor and chlordane [7,13]. These compounds are neurotoxic and exert their effects on target organisms by rapidly opening sodium (Na+) channels in neurons, which results in the continuous stimulation of cellular receptors [14,15]. Although remarkably efficacious against insects, the use of OC insecticides in agriculture is now largely banned worldwide, owing to the significant teratogenic and carcinogenic effects observed in wildlife and livestock, as well as humans. Further off-target effects including carcinogenesis, hypertrophy and reduced fertility in rodent models, as well as genotoxicity, reduced fertility and neurotoxicity [16], have dictated the rapid development of alternative insecticides.
Today, the vast majority of insecticides used are organophosphates (OP), which, although also neurotoxic, are generally considered a “safer” alternative [17], as the levels of bioaccumulation (accumulation of chemicals inside an organism through direct or indirect uptake) are far lower for OP rather than OC insecticides [18]. Moreover, OP insecticides are further favoured in agricultural settings due to their cost effectiveness [1] as well as their rapid mode of action (immediate neurotoxicity) against a wide variety of target organisms, leading to broad-spectrum success in pest elimination [19]. The most commonly used OPs are shown in Table 1, and include chemicals to safeguard livestock in both terrestrial and aquatic-based farming approaches.

3. OPs—Mode of Action In Vivo

The primary neurotoxic action of organophosphate (OP) insecticide exposure is the irreversible inhibition of acetylcholinesterase (AChE) in the synaptic junction of neurons (Figure 1), leading to the hyperstimulation of post-synaptic cells [7,20]. At a biochemical level, OPs bind to the hydroxyl group of AChE through phosphorylation, preventing AChE from hydrolysing ACh [21]. In turn, the reduction of AChE activity results in an abnormal build-up of ACh in the synaptic junctions, leading to hyperstimulation of the muscarinic and nicotinic receptors involved in cholinergic pathways [22]. Therefore, increased OP exposure is likely to substantially impact upon neural function, and the risk of OP-dependent toxicity can be quantitated through measuring AChE levels and activity in blood [23] and pesticide metabolites, such as dialkyl phosphate (DAP) compounds in urine [24,25] and plasma [26].
AChE is integral for regulating neurotransmission [27], achieved through the hydrolysing of acetylcholine (ACh) into its two structural products, acetyl CoA and choline, the latter of which is returned to the pre-synaptic neuron via the sodium (Na+) choline transporter, enabling regeneration of ACh in the pre-synaptic neuron. This process occurs in the central nervous system (CNS) within the brainstem, striatum and basal forebrain [28], as well as in the peripheral nervous system (PNS) at both the neuroglandular and neuromuscular junctions [29]. ACh from pre-synaptic neurons plays important roles in initiating skeletal, smooth and cardiac muscle contraction, and more recently have been implicated in the development and maturation of the brain [30,31,32].
As a result of acute and chronic exposure, OPs can cause extensive damage to cells including cytotoxicity, apoptosis [33,34], genotoxicity and subsequent DNA mutations [35]. In previous studies, pesticides have been shown to produce covalent adducts with DNA, and as a result form interstrand cross-links which inhibit cellular replication and transcription [36]. Given that DNA adducts are destructive compounds that cause cellular damage, they are nonetheless useful biomarkers for identifying oxidative stress and genotoxicity [37].
Other cellular irregularities identified include increases in cytokine secretion (particularly tumour necrosis factor and interleukin 6) through neuroinflammation, improper clearance of reactive oxygen species, and pathologically-induced alterations in gene expression [38,39,40].

4. OPs—Occupational, Household and Waterway Exposure

Although OP insecticides are highly effective, it is estimated that only 0.1% of these pesticides reach their target organisms [41,42], with the majority being lost in soil, food and drainage [22,43,44]; in fact, OPs are the most common synthetic material found in waterways, soil and animal tissues [5]. OP exposure is generally considered to be most problematic in agricultural environments, and indeed occupational settings, such as farms and factories, contribute a significant avenue of OP exposure. However, OP exposure frequently occurs also in the household environment through food contamination and oral/epidermal exposure [27]. Although less common than occupational exposure, residential OP exposure can occur from the use of these insecticides in the household or garden (Figure 2), and usually occur from improper storage and spills [45]. Additionally, the infiltration of OPs in the diet, where OPs are consistently detected in foods at low levels [46], is considered to be a significant route of exposure and subsequent poisonings [47]. Children are particularly vulnerable to OP exposure through diet due to the fact that they eat 2.8–4.8 times more food per unit of body mass, and the types of food that they eat (fruits and vegetables) contain higher levels of OP residues [47,48]. Although techniques do exist for monitoring environmental OP exposure (surrogate skin, fluorescent tracers, air sampling pumps, etc.), most OPs are only detected once they have entered the body [49]. Therefore, greater understanding of the lifelong effects of OP exposure are necessary in order to better govern their use and mandate appropriate safety measures for use where the likelihood of human ingestion is high.
Waterway exposure can occur unintentionally via agricultural surface run-off, creating a significant risk not only directly to aquatic ecosystems, but indirectly to humans as well [50]. OPs can also be intentionally released into waterways, a phenomenon commonly observed in commercial fish farms and fishing sports that use these substances to eliminate water-borne pests [51] such as flat worm parasites [52]. Assessing chronic OP exposure in waterways is challenging owing to high OP solubility, relatively short half-lives, and relatively low bioaccumulation [53]; however, data suggest that OP contamination is of global concern. With 95% of urban streams in the US showing detectable levels of OP contamination [54], one can assume that aquatic species are consistently exposed to OP insecticides for prolonged periods.

5. Major Findings: The Zebrafish as Model for Testing Organophosphate (OP) Insecticides

The use of mammalian models such as mice for screening experiments is both expensive and, owing to the relatively lengthy gestation periods, time consuming. Therefore, alternate animal models of environmental susceptibility, which are low cost and high-throughput, are desirable for toxin-screening, as these would provide rapid functional data that could narrow down OPs of interest and allow for subsequent targeted testing in mammalian models.
One such model is the zebrafish (Danio rerio), which has become a favoured model for developmental research [55]. The zebrafish is an excellent model of human diseases, as the zebrafish and human genome share more than ~80% similarity [56]. This well-established genetic conservation of the zebrafish is one of the reasons why it is supported as a model for environmental toxicology studies, specifically in relation to vertebrate embryogenesis [57]. The rapid rate in which the structures of the zebrafish develop, coupled with optical clarity and ease of access, makes it a model of choice for observing embryo development.
The toxic effects of OP insecticides at early developmental stages of zebrafish embryogenesis have been investigated in multiple studies, which for the first time we have collated here (Table 2). From an embryological toxicity standpoint, a substantial number of these studies employed an acute exposure period from 0–5 h post-fertilization (hpf), allowing early phenotypes to be investigated. These timepoints coincide with the initial critical stages of cellular proliferation, migration (epiboly) and the onset of gastrulation, processes essential for the establishment of the three germinal layers and subsequent patterning of tissue primordia. The consequences of OP exposure in these acute early-stage studies are diverse; however, various morphological (spinal, yolk sac, body length, pigment and eye surface area), physiological (heart rate, AChE levels, genetic), and behavioural (locomotor activity, anxiety) impairments are commonly identified. Exposure to OPs at zebrafish adult stages led to predominately behavioural (anxiety, startle response) and physiological (ATP, AChE, GSH, MDA, etc.) irregularities, with fewer concomitant morphological impairments, highly consistent with lifelong morbidity as a consequence of acute exposure primarily in the early stages of development.
While symptoms and defects present in zebrafish models do not always accurately predict human disease, the broad effects of OP on development appear consistent across both fish and humans. The neurological effects of OP in development appear largely consistent across species and correlate with the known mechanism of action of OP on the cholinergic system. Further, the >80% commonality in genome between zebrafish and humans indicates that zebrafish studies are valuable for identifying the molecular changes that may be common to harmful OP exposure in humans and zebrafish. To this end, we believe our summary table will serve as an invaluable resource for future continued implementation of the zebrafish in determining consequences for human OP-dependent disease, as indicated in the sections below.

6. Organophosphate Toxicity—Acute Cholinergic Syndrome (ACS)

Although having conserved function as a neurotoxin, the phenotypic consequences of OP exposure are nonetheless extremely variable, and symptoms may manifest following either acute (high dose) or chronic (typically lower dose) exposure (Figure 3). The earliest stage of OP toxicity is referred to as acute cholinergic syndrome (ACS), which is a result of the effects of AChE inhibition [93]. ACS can occur within minutes of OP exposure, and impairs both muscarinic and nicotinic receptors found in the nervous system [94]. The consequences of hyper-stimulated post-synaptic receptors (hyperstimulation) vary depending on their locations. In the CNS, hyperstimulation more commonly occurs at muscarinic receptors, resulting in heart irregularities, gastrointestinal issues including stomach cramps, diarrhoea and vomiting, respiratory complications including bronchorrhea and bronchospasms, as well as neurological effects including seizures, agitations and anxiety [95,96]. Comparatively, hyperstimulation in the PNS is more commonly associated with nicotinic receptors, and this is often expressed as muscle weakness, cramps or paralysis [7,97]. Symptoms of OP exposure are quite complex in that they are not limited to a localised area and are a result of the diverse effect of OPs on both CNS and PNS pathways.

7. Organophosphate Toxicity—Intermediate Syndrome (IMS)

The intermediate syndrome (IMS) follows 1–4 days after ACS (Figure 4), and is characterised as the onset of muscle weakness, particularly in the proximal limbs, neck and respiratory system [98]. If untreated, from 14–21 days after acute exposure, weakness in the peripheral muscles becomes evident [49]. It is estimated that only ~20% of humans exposed to OP will have symptoms that progress from ACS to the IMS stage [99]. The IMS is commonly associated with respiratory failure as a result of nicotinic receptor paralysis. Respiratory failure from prolonged OP exposure is primarily linked to the CNS, specifically the depression of the pre-Botzinger complex (glutaminergic and muscarinic fibres) located in the ventrolateral medulla in the brainstem [100]. This has resulted in respiratory failure being recognised as a significant comorbidity in OP mortality [94].

8. Organophosphate Toxicity—Organophosphate-Induced Delayed Neuropathy (OPIDN)

OP toxicity does not solely result in AChE inhibition, and depending on the physical structure of the compound, OPs can target other secondary hydroxyl sites on enzymes other than AChE [101]. OP insecticide exposure can also give rise to another type of toxicity, referred to as organophosphate-induced delayed neuropathy (OPIDN), which, depending on dose and chemical structure, occurs ~2–3 weeks after ACS [94,102]. This pathology is characterised as the degeneration of distal axons in the CNS and PNS, is expressed as sensory loss in both hands and feet, weakness in distal muscles and coordination issues [7] and is associated with the inhibition of neuropathy-target-esterase (NTE) [103]. NTE is an integral enzyme employed at the neurite initiation stage of neuronal morphogenesis, with these neurites maturing into axons and dendrites to form part of the nervous system [104].
Importantly, the consequences of OPIDN are only present when ≥70% of NTE is inhibited [105]. Additionally, in order for irreversible inhibition of NTE, there must be a secondary chemical reaction, where there is a displacement of an R-group (aging) [103], and, therefore, NTE inhibition and OPIDN is thought to contribute to diseases characterised by axonal degradation such as Alzheimer’s disease, Parkinson’s disease and motor neuron diseases (MND) that include amyotrophic lateral sclerosis (ALS) and progressive bulbar palsy [106]. As these diseases are primarily associated with aging in humans, it is interesting to note that animal models show that adults are both far more susceptible to, and recover far more poorly from, OPIDN than juveniles [106].
The inhibition of NTE itself is not responsible for axonal degeneration, as has been demonstrated with non-OP inhibitors (organophosphinates, sulfonyl fluorides and carbamates) that covalently react with NTE, but do not undergo the enzyme ageing process [107]; this indicates that R-group displacement confers a “gain” of neurotoxicity that is damaging in its own right.

9. Organophosphate Toxicity—Effects on Embryogenesis

Pre-natal OP exposure is of particular concern, as developing babies are highly susceptible to chemical injury [108,109]. This is partly a result of their immature detoxification mechanisms, i.e., reduced expression of OP specific detoxifying enzymes such as paraoxonase and chlorpyrifos-oxonase, compared to adults [110,111], and also as the cholinergic system (which is targeted by OPs) is heavily involved with placental processes including amino acid uptake and nitric oxide signalling [112]. Pre-natal OP exposure has been associated with shortened gestational periods [113], reduced birth weight and birth length [114], as well as impaired reflexes [115] and neurobehavioral irregularities [116].
While the influence of OPs on the mature blood brain barrier (BBB) is unclear, the developing and newborn BBB is “leaky”, allowing toxins, in particularly pesticides in the fetal circulation, to cross and have negative effects on the developing brain [117,118]. Overall, the neurotoxic properties of OPs, and the resultant syndromes have been reasonably well documented (Figure 4), with AChE inhibition and hyperstimulation of postsynaptic neurons being key contributors to these impairments [119].

10. Organophosphate Toxicity—Effects on Neurodevelopment and Early Behaviour

The timing of prenatal OP exposure plays a critical role in fetal development and postnatal behaviour. OP exposure during the 1st and 2nd trimester of pregnancy has been shown to be associated with delayed cognitive performance at both 2 and 6 months of age, whereas OP exposure in the 3rd trimester of pregnancy is associated with delayed communication and motor performance at 6 months of age [120].
In terms of neurodevelopmental impairments, OPs such as chlorpyrifos and diazinon have been shown to cause decreased DNA synthesis in neuronotypic PC12 and gliotypic C6 neural cell lines, the latter of which continues to develop into the postnatal period [121]. Additionally, children aged ~3 years have been identified as having increased risk of displaying developmental delays and a higher incidence of behavioural disorders such as ADHD [108,122], and prenatal exposure to OP insecticides was associated with poorer intellectual development in seven year old children [123], as well as poorer motor skills and cognitive recall when compared to non-exposed children [124]. Taken together, these studies show that not only does pre-natal exposure to OPs affect embryogenesis, but also cognitive development in young children.

11. Organophosphate Toxicity—Effects in Adulthood and Neurodegenerative Diseases

Whilst infants and children are highly susceptible to OP insecticide toxicity, these chemicals have also been associated with impaired health at later stages of life, particularly neurological disorders such as Alzheimer’s Disease (AD) and Parkinson’s Disease (PD) [125]. Recent studies have shown that chronic exposure in agricultural workers is associated with neural irregularities including neurodegenerative diseases, attention impairment and short-term memory loss [11]. The cholinergic system, which is affected by OP insecticides, has long been associated with neurodegenerative diseases, with ACh one of the key neurotransmitters involved in cellular signalling in the brain [125]. The reduction of ACh is a critical element in memory loss diseases such as AD, where ACh in the basal forebrain is known to play an integral role in memory and learning; as OP insecticides promote an imbalance of ACh at cellular junctions in the brain, these chemicals are, therefore, linked to impaired memory diseases [126].
Although PD involves a depletion of dopaminergic cell bodies, it is symptomatically dissimilar to AD in that it is characterised by motor impairments such as tremor at early onset and posture/gait issues at later stages [127]. Along with genetic predisposition, pesticides are widely acknowledged as an environmental risk factor for PD, with OPs having been implicated in some studies of the disease [128,129,130]. Variability in the PON1 gene (when exposed to various OPs—diazinon/chlorpyrifos) has been shown to correlate with a greater than two-fold increase in PD risk [131]. Despite the causal relationship being still largely unknown, an epidemiological analysis of 23 case-control studies found that 13 of the studies reported a statistically significant risk of PD with pesticide exposure, with both chlorpyrifos (OP) and organochlorines (OC) being key contributors to the study [132]. However, one limitation of pesticide research on neurodegenerative diseases such as PD is that the study of pesticides does not encompass the lifespan, making it difficult to analyse the long term effects of these chemicals [133].

12. Conclusions

Rapid population growth and changing diets in developing countries have increased the demand for food, to the point that food production must increase by 70% to meet the estimated food demands in 2050 [134]. Pesticides will play an essential role in achieving this production increase. While the economic and societal benefits of pesticides are inarguable, the effects of pesticide exposure on non-target animals and humans are a continuing concern. Of note is the growing use of OP insecticides, which are linked to poor neurodevelopment in both developed and developing countries worldwide. While our understanding of the relationship between OP exposure and poor health outcomes is growing, it remains unclear the extent to which AChE inhibition and OP exposure lead to developmental abnormalities. However, addressing this relationship between OP exposure and neurodevelopment and behaviour will encourage improvements in the regulation of use and handling of OPs in agricultural, industrial and domestic environments around the world.

Author Contributions

Conceptualization, J.N. and S.D.; writing—original draft preparation, J.N., J.N.F., C.v.d.P., J.E.C. and S.D., writing—review and editing, J.N., J.N.F., C.v.d.P., J.E.C. and S.D.; project administration, S.D., funding acquisition, S.D. All authors have read and agreed to the published version of the manuscript.

Funding

This work was supported by a La Trobe University Securing Food, Water and the Environment, Research Focus Area Grant Ready Grant #3.2509.07.48.

Institutional Review Board Statement

Not Applicable.

Informed Consent Statement

Not Applicable.

Data Availability Statement

Not Applicable.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Pamanji, R.; Bethu, M.S.; Yashwanth, B.; Leelavathi, S.; Venkateswara Rao, J. Developmental toxic effects of monocrotophos, an organophosphorous pesticide, on zebrafish (Danio rerio) embryos. Environ. Sci. Pollut Res. Int. 2015, 22, 7744–7753. [Google Scholar] [CrossRef] [PubMed]
  2. Velki, M.; Di Paolo, C.; Nelles, J.; Seiler, T.B.; Hollert, H. Diuron and diazinon alter the behavior of zebrafish embryos and larvae in the absence of acute toxicity. Chemosphere 2017, 180, 65–76. [Google Scholar] [CrossRef] [PubMed]
  3. Zhang, C.; Shi, G.M.; Shen, J.; Hu, R.F. Productivity effect and overuse of pesticide in crop production in China. J. Integr. Agr. 2015, 14, 1903–1910. [Google Scholar] [CrossRef]
  4. Zhang, Z.Y.; Yu, X.Y.; Wang, D.L.; Yan, H.J.; Liu, X.J. Acute toxicity to zebrafish of two organophosphates and four pyrethroids and their binary mixtures. Pest Manag. Sci. 2010, 66, 84–89. [Google Scholar] [CrossRef]
  5. Naughton, S.X.; Terry, A.V., Jr. Neurotoxicity in acute and repeated organophosphate exposure. Toxicology 2018, 408, 101–112. [Google Scholar] [CrossRef]
  6. van den Berg, H.; da Silva Bezerra, H.S.; Al-Eryani, S.; Chanda, E.; Nagpal, B.N.; Knox, T.B.; Velayudhan, R.; Yadav, R.S. Recent trends in global insecticide use for disease vector control and potential implications for resistance management. Sci. Rep. 2021, 11, 23867. [Google Scholar] [CrossRef]
  7. Richardson, J.R.; Fitsanakis, V.; Westerink, R.H.S.; Kanthasamy, A.G. Neurotoxicity of pesticides. Acta Neuropathol. 2019, 138, 343–362. [Google Scholar] [CrossRef]
  8. Barton, P.S.; Evans, M.J. Insect biodiversity meets ecosystem function: Differential effects of habitat and insects on carrion decomposition. Ecol. Entomol. 2017, 42, 364–374. [Google Scholar] [CrossRef]
  9. Scudder, G.G.E. The Importance of Insects. In Insect Biodiversity: Science and Society, 2nd ed.; John Wiley & Sons: Hoboken, NJ, USA, 2017; Volume 1. [Google Scholar]
  10. APVMA. Agricultural and veterinary chemicals. In Authority; The Australian Pesticides and Veterinary Medicines Authority: Kingston, ACT, Australia, 2014. [Google Scholar]
  11. Perry, J.; Cotton, J.; Rahman, M.A.; Brumby, S.A. Organophosphate exposure and the chronic effects on farmers: A narrative review. Rural Remote Health 2020, 20, 4508. [Google Scholar] [CrossRef]
  12. Bonner, M.R.; Freeman, L.E.; Hoppin, J.A.; Koutros, S.; Sandler, D.P.; Lynch, C.F.; Hines, C.J.; Thomas, K.; Blair, A.; Alavanja, M.C. Occupational exposure to pesticides and the incidence of lung cancer in the agricultural health study. Environ. Health Perspect. 2017, 125, 544–551. [Google Scholar] [CrossRef]
  13. Kaushik, P.; Kaushik, G. An assessment of structure and toxicity correlation in organochlorine pesticides. J. Hazard Mater. 2007, 143, 102–111. [Google Scholar] [CrossRef] [PubMed]
  14. Bloomquist, J.R.; Soderlund, D.M. Pyrethroid insecticides and DDT modify alkaloid-dependent sodium channel activation and its enhancement by sea anemone toxin. Mol. Pharmacol. 1988, 33, 543–550. [Google Scholar]
  15. Karami-Mohajeri, S.; Abdollahi, M. Toxic influence of organophosphate, carbamate, and organochlorine pesticides on cellular metabolism of lipids, proteins, and carbohydrates: A systematic review. Hum. Exp. Toxicol. 2011, 30, 1119–1140. [Google Scholar] [CrossRef] [PubMed]
  16. Jayaraj, R.; Megha, P.; Sreedev, P. Organochlorine pesticides, their toxic effects on living organisms and their fate in the environment. Interdiscip. Toxicol. 2016, 9, 90–100. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  17. Cohen, M. Environmental toxins and health--the health impact of pesticides. Aust. Fam. Physician 2007, 36, 1002–1004. [Google Scholar] [PubMed]
  18. Cao, F.; Souders, C.L., 2nd; Li, P.; Pang, S.; Qiu, L.; Martyniuk, C.J. Biological impacts of organophosphates chlorpyrifos and diazinon on development, mitochondrial bioenergetics, and locomotor activity in zebrafish (Danio rerio). Neurotoxicol. Teratol. 2018, 70, 18–27. [Google Scholar] [CrossRef]
  19. Modra, H.; Vrskova, D.; Macova, S.; Kohoutkova, J.; Hajslova, J.; Haluzova, I.; Svobodova, Z. Comparison of diazinon toxicity to embryos of Xenopus laevis and Danio rerio; degradation of diazinon in water. Bull. Environ. Contam. Toxicol. 2011, 86, 601–604. [Google Scholar] [CrossRef]
  20. Pope, C.N.; Chakraborti, T.K. Dose-related inhibition of brain and plasma cholinesterase in neonatal and adult rats following sublethal organophosphate exposures. Toxicology 1992, 73, 35–43. [Google Scholar] [CrossRef]
  21. Marrs, T.C. Organophosphate poisoning. Pharmacol. Ther. 1993, 58, 51–66. [Google Scholar] [CrossRef]
  22. Costa, L.G. Current issues in organophosphate toxicology. Clin. Chim. Acta 2006, 366, 1–13. [Google Scholar] [CrossRef] [PubMed]
  23. Abass, K.S. Experimental measurements for the effect of dilution procedure in blood esterases as animals biomarker for exposure to OP compounds. Biomed. Res. Int. 2014, 2014, 451982. [Google Scholar] [CrossRef]
  24. Wessels, D.; Barr, D.B.; Mendola, P. Use of biomarkers to indicate exposure of children to organophosphate pesticides: Implications for a longitudinal study of children’s environmental health. Environ. Health Perspect. 2003, 111, 1939–1946. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  25. Lambert, W.E.; Lasarev, M.; Muniz, J.; Scherer, J.; Rothlein, J.; Santana, J.; McCauley, L. Variation in organophosphate pesticide metabolites in urine of children living in agricultural communities. Environ. Health Perspect. 2005, 113, 504–508. [Google Scholar] [CrossRef] [Green Version]
  26. Munoz-Quezada, M.T.; Lucero, B.; Bradman, A.; Baumert, B.; Iglesias, V.; Munoz, M.P.; Concha, C. Reliability and factorial validity of a questionnaire to assess organophosphate pesticide exposure to agricultural workers in Maule, Chile. Int. J. Environ. Health Res. 2019, 29, 45–59. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  27. Reiss, R.; Chang, E.T.; Richardson, R.J.; Goodman, M. A review of epidemiologic studies of low-level exposures to organophosphorus insecticides in non-occupational populations. Crit. Rev. Toxicol. 2015, 45, 531–641. [Google Scholar] [CrossRef]
  28. Maurer, S.V.; Williams, C.L. The Cholinergic System Modulates Memory and Hippocampal Plasticity via Its Interactions with Non-Neuronal Cells. Front. Immunol. 2017, 8, 1489. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  29. Silva, M.H. Effects of low-dose chlorpyrifos on neurobehavior and potential mechanisms: A review of studies in rodents, zebrafish, and Caenorhabditis elegans. Birth Defects Res. 2020, 112, 445–479. [Google Scholar] [CrossRef]
  30. Daubas, P.; Devillers-Thiery, A.; Geoffroy, B.; Martinez, S.; Bessis, A.; Changeux, J.P. Differential expression of the neuronal acetylcholine receptor alpha 2 subunit gene during chick brain development. Neuron 1990, 5, 49–60. [Google Scholar] [CrossRef]
  31. Obis, T.; Besalduch, N.; Hurtado, E.; Nadal, L.; Santafe, M.M.; Garcia, N.; Tomas, M.; Priego, M.; Lanuza, M.A.; Tomas, J. The novel protein kinase C epsilon isoform at the adult neuromuscular synapse: Location, regulation by synaptic activity-dependent muscle contraction through TrkB signaling and coupling to ACh release. Mol. Brain 2015, 8, 8. [Google Scholar] [CrossRef] [Green Version]
  32. Obis, T.; Hurtado, E.; Nadal, L.; Tomas, M.; Priego, M.; Simon, A.; Garcia, N.; Santafe, M.M.; Lanuza, M.A.; Tomas, J. The novel protein kinase C epsilon isoform modulates acetylcholine release in the rat neuromuscular junction. Mol. Brain 2015, 8, 80. [Google Scholar] [CrossRef] [Green Version]
  33. Akbarsha, M.A.; Sivasamy, P. Male reproductive toxicity of phosphamidon: Histopathological changes in epididymis. Indian J. Exp. Biol. 1998, 36, 34–38. [Google Scholar] [PubMed]
  34. Hamm, J.T.; Wilson, B.W.; Hinton, D.E. Organophosphate-induced acetylcholinesterase inhibition and embryonic retinal cell necrosis in vivo in the teleost (Oryzias latipes). Neurotoxicology 1998, 19, 853–869. [Google Scholar] [PubMed]
  35. Barranger, A.; Benabdelmouna, A.; Degremont, L.; Burgeot, T.; Akcha, F. Parental exposure to environmental concentrations of diuron leads to aneuploidy in embryos of the Pacific oyster, as evidenced by fluorescent in situ hybridization. Aquat Toxicol. 2015, 159, 36–43. [Google Scholar] [CrossRef] [Green Version]
  36. Cui, Y.; Guo, J.; Xu, B.; Chen, Z. Potential of chlorpyrifos and cypermethrin forming DNA adducts. Mutat Res. 2006, 604, 36–41. [Google Scholar] [CrossRef] [PubMed]
  37. Autrup, H.; Daneshvar, B.; Dragsted, L.O.; Gamborg, M.; Hansen, M.; Loft, S.; Okkels, H.; Nielsen, F.; Nielsen, P.S.; Raffn, E.; et al. Biomarkers for exposure to ambient air pollution--comparison of carcinogen-DNA adduct levels with other exposure markers and markers for oxidative stress. Environ. Health Perspect. 1999, 107, 233–238. [Google Scholar]
  38. Moyano, P.; Del Pino, J.; Anadon, M.J.; Diaz, M.J.; Gomez, G.; Frejo, M.T. Toxicogenomic profile of apoptotic and necrotic SN56 basal forebrain cholinergic neuronal loss after acute and long-term chlorpyrifos exposure. Neurotoxicol. Teratol. 2017, 59, 68–73. [Google Scholar] [CrossRef]
  39. Mohammadzadeh, L.; Hosseinzadeh, H.; Abnous, K.; Razavi, B.M. Neuroprotective potential of crocin against malathion-induced motor deficit and neurochemical alterations in rats. Environ. Sci. Pollut. Res. Int. 2018, 25, 4904–4914. [Google Scholar] [CrossRef]
  40. Eftekhari, A.; Ahmadian, E.; Azami, A.; Johari-Ahar, M.; Eghbal, M.A. Protective effects of coenzyme Q10 nanoparticles on dichlorvos-induced hepatotoxicity and mitochondrial/lysosomal injury. Environ. Toxicol. 2018, 33, 167–177. [Google Scholar] [CrossRef]
  41. Pimentel, D.; Levitan, L. Pesticides—Amounts applied and amounts reaching pests. BioScience 1986, 36, 86–91. [Google Scholar] [CrossRef]
  42. Pimentel, D. Amounts of pesticides reaching target pests: Environmental impacts and ethics. J. Agric. Environ. Ethics 1995, 8, 17–29. [Google Scholar] [CrossRef]
  43. Galloway, T.; Handy, R. Immunotoxicity of organophosphorous pesticides. Ecotoxicology 2003, 12, 345–363. [Google Scholar] [CrossRef]
  44. Ghazala; Mahboob, S.; Ahmad, L.; Sultana, S.; Alghanim, K.; Al-Misned, F.; Ahmad, Z. Fish cholinesterases as biomarkers of sublethal effects of organophosphorus and carbamates in tissues of Labeo rohita. J. Biochem. Mol. Toxicol. 2014, 28, 137–142. [Google Scholar] [CrossRef] [PubMed]
  45. Jaga, K.; Dharmani, C. Sources of exposure to and public health implications of organophosphate pesticides. Rev. Panam. Salud Publica 2003, 14, 171–185. [Google Scholar] [CrossRef] [Green Version]
  46. Oates, L.; Cohen, M.; Braun, L.; Schembri, A.; Taskova, R. Reduction in urinary organophosphate pesticide metabolites in adults after a week-long organic diet. Environ. Res. 2014, 132, 105–111. [Google Scholar] [CrossRef] [Green Version]
  47. Fenske, R.A.; Kedan, G.; Lu, C.; Fisker-Andersen, J.A.; Curl, C.L. Assessment of organophosphorous pesticide exposures in the diets of preschool children in Washington State. J. Expo. Anal. Environ. Epidemiol. 2002, 12, 21–28. [Google Scholar] [CrossRef] [Green Version]
  48. Holme, F.; Thompson, B.; Holte, S.; Vigoren, E.M.; Espinoza, N.; Ulrich, A.; Griffith, W.; Faustman, E.M. The role of diet in children’s exposure to organophosphate pesticides. Environ. Res. 2016, 147, 133–140. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  49. Kamanyire, R.; Karalliedde, L. Organophosphate toxicity and occupational exposure. Occup. Med. 2004, 54, 69–75. [Google Scholar] [CrossRef] [Green Version]
  50. Jin, Y.; Liu, Z.; Peng, T.; Fu, Z. The toxicity of chlorpyrifos on the early life stage of zebrafish: A survey on the endpoints at development, locomotor behavior, oxidative stress and immunotoxicity. Fish Shellfish. Immunol. 2015, 43, 405–414. [Google Scholar] [CrossRef] [PubMed]
  51. Baldissera, M.D.; Souza, C.F.; Zanella, R.; Prestes, O.D.; Meinhart, A.D.; Da Silva, A.S.; Baldisserotto, B. Behavioral impairment and neurotoxic responses of silver catfish Rhamdia quelen exposed to organophosphate pesticide trichlorfon: Protective effects of diet containing rutin. Comp. Biochem. Physiol. C Toxicol. Pharmacol. 2020, 239, 108871. [Google Scholar] [CrossRef]
  52. Trujillo-Gonzalez, A.; Becker, J.A.; Vaughan, D.B.; Hutson, K.S. Monogenean parasites infect ornamental fish imported to Australia. Parasitol. Res. 2018, 117, 995–1011. [Google Scholar] [CrossRef] [PubMed]
  53. Gruber, S.J.; Munn, M.D. Organophosphate and carbamate insecticides in agricultural waters and cholinesterase (ChE) inhibition in common carp (Cyprinus carpio). Arch. Environ. Contam. Toxicol. 1998, 35, 391–396. [Google Scholar] [CrossRef]
  54. Gilliom, R.J.; Barbash, J.E.; Kolpin, D.W.; Larson, S.J. Peer reviewed: Testing water quality for pesticide pollution. Environ. Sci. Technol. 1999, 33, 164A–169A. [Google Scholar] [CrossRef] [PubMed]
  55. Dai, Y.J.; Jia, Y.F.; Chen, N.; Bian, W.P.; Li, Q.K.; Ma, Y.B.; Chen, Y.L.; Pei, D.S. Zebrafish as a model system to study toxicology. Environ. Toxicol. Chem. 2014, 33, 11–17. [Google Scholar] [CrossRef] [PubMed]
  56. Wang, X.; Shen, M.; Zhou, J.; Jin, Y. Chlorpyrifos disturbs hepatic metabolism associated with oxidative stress and gut microbiota dysbiosis in adult zebrafish. Comp. Biochem. Physiol. C Toxicol. Pharmacol. 2019, 216, 19–28. [Google Scholar] [CrossRef]
  57. Shen, W.; Lou, B.; Xu, C.; Yang, G.; Yu, R.; Wang, X.; Li, X.; Wang, Q.; Wang, Y. Lethal toxicity and gene expression changes in embryonic zebrafish upon exposure to individual and mixture of malathion, chlorpyrifos and lambda-cyhalothrin. Chemosphere 2020, 239, 124802. [Google Scholar] [CrossRef] [PubMed]
  58. Levin, E.D.; Chrysanthis, E.; Yacisin, K.; Linney, E. Chlorpyrifos exposure of developing zebrafish: Effects on survival and long-term effects on response latency and spatial discrimination. Neurotoxicol. Teratol. 2003, 25, 51–57. [Google Scholar] [CrossRef]
  59. Levin, E.D.; Swain, H.A.; Donerly, S.; Linney, E. Developmental chlorpyrifos effects on hatchling zebrafish swimming behavior. Neurotoxicol. Teratol 2004, 26, 719–723. [Google Scholar] [CrossRef] [PubMed]
  60. Cook, L.W.; Paradise, C.J.; Lom, B. The pesticide malathion reduces survival and growth in developing zebrafish. Environ. Toxicol. Chem. 2005, 24, 1745–1750. [Google Scholar] [CrossRef]
  61. Senger, M.R.; Rico, E.P.; de Bem Arizi, M.; Rosemberg, D.B.; Dias, R.D.; Bogo, M.R.; Bonan, C.D. Carbofuran and malathion inhibit nucleotide hydrolysis in zebrafish (Danio rerio) brain membranes. Toxicology 2005, 212, 107–115. [Google Scholar] [CrossRef]
  62. Osterauer, R.; Kohler, H.R. Temperature-dependent effects of the pesticides thiacloprid and diazinon on the embryonic development of zebrafish (Danio rerio). Aquat. Toxicol. 2008, 86, 485–494. [Google Scholar] [CrossRef]
  63. Kienle, C.; Kohler, H.R.; Gerhardt, A. Behavioural and developmental toxicity of chlorpyrifos and nickel chloride to zebrafish (Danio rerio) embryos and larvae. EcoToxicol. Environ. Saf. 2009, 72, 1740–1747. [Google Scholar] [CrossRef]
  64. Jacobson, K.A. Introduction to adenosine receptors as therapeutic targets. Handb. Exp. Pharmacol. 2009, 193, 1–24. [Google Scholar]
  65. Eddins, D.; Cerutti, D.; Williams, P.; Linney, E.; Levin, E.D. Zebrafish provide a sensitive model of persisting neurobehavioral effects of developmental chlorpyrifos exposure: Comparison with nicotine and pilocarpine effects and relationship to dopamine deficits. Neurotoxicol. Teratol. 2010, 32, 99–108. [Google Scholar] [CrossRef]
  66. Jacobson, S.M.; Birkholz, D.A.; McNamara, M.L.; Bharate, S.B.; George, K.M. Subacute developmental exposure of zebrafish to the organophosphate pesticide metabolite, chlorpyrifos-oxon, results in defects in Rohon-Beard sensory neuron development. Aquat. Toxicol. 2010, 100, 101–111. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  67. Sisman, T. Dichlorvos-induced developmental toxicity in zebrafish. Toxicol. Ind. Health 2010, 26, 567–573. [Google Scholar] [CrossRef]
  68. Tilton, F.A.; Bammler, T.K.; Gallagher, E.P. Swimming impairment and acetylcholinesterase inhibition in zebrafish exposed to copper or chlorpyrifos separately, or as mixtures. Comp. Biochem. Physiol. C Toxicol. Pharmacol. 2011, 153, 9–16. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  69. Yang, D.; Lauridsen, H.; Buels, K.; Chi, L.H.; La Du, J.; Bruun, D.A.; Olson, J.R.; Tanguay, R.L.; Lein, P.J. Chlorpyrifos-oxon disrupts zebrafish axonal growth and motor behavior. Toxicol. Sci. 2011, 121, 146–159. [Google Scholar] [CrossRef] [Green Version]
  70. Yen, J.; Donerly, S.; Levin, E.D.; Linney, E.A. Differential acetylcholinesterase inhibition of chlorpyrifos, diazinon and parathion in larval zebrafish. Neurotoxicol. Teratol. 2011, 33, 735–741. [Google Scholar] [CrossRef] [Green Version]
  71. Richendrfer, H.; Pelkowski, S.D.; Colwill, R.M.; Creton, R. Developmental sub-chronic exposure to chlorpyrifos reduces anxiety-related behavior in zebrafish larvae. Neurotoxicol. Teratol. 2012, 34, 458–465. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  72. Zhang, X.; Gao, L.; Yang, K.; Tian, H.; Wang, W.; Ru, S. Monocrotophos pesticide modulates the expression of sexual differentiation genes and causes phenotypic feminization in zebrafish (Danio rerio). Comp. Biochem. Physiol. C Toxicol. Pharmacol. 2013, 157, 33–40. [Google Scholar] [CrossRef]
  73. Watson, F.L.; Schmidt, H.; Turman, Z.K.; Hole, N.; Garcia, H.; Gregg, J.; Tilghman, J.; Fradinger, E.A. Organophosphate pesticides induce morphological abnormalities and decrease locomotor activity and heart rate in Danio rerio and Xenopus laevis. Environ. Toxicol. Chem. 2014, 33, 1337–1345. [Google Scholar] [CrossRef] [PubMed]
  74. Rodriguez-Fuentes, G.; Rubio-Escalante, F.J.; Norena-Barroso, E.; Escalante-Herrera, K.S.; Schlenk, D. Impacts of oxidative stress on acetylcholinesterase transcription, and activity in embryos of zebrafish (Danio rerio) following Chlorpyrifos exposure. Comp. Biochem. Physiol. C Toxicol. Pharmacol. 2015, 172–173, 19–25. [Google Scholar] [CrossRef] [PubMed]
  75. Bui-Nguyen, T.M.; Baer, C.E.; Lewis, J.A.; Yang, D.; Lein, P.J.; Jackson, D.A. Dichlorvos exposure results in large scale disruption of energy metabolism in the liver of the zebrafish, Danio rerio. BMC Genomics 2015, 16, 853. [Google Scholar] [CrossRef] [PubMed]
  76. Zhang, X.; Zhong, Y.; Tian, H.; Wang, W.; Ru, S. Impairment of the cortisol stress response mediated by the hypothalamus-pituitary-interrenal (HPI) axis in zebrafish (Danio rerio) exposed to monocrotophos pesticide. Comp. Biochem. Physiol. C Toxicol. Pharmacol. 2015, 176–177, 10–16. [Google Scholar] [CrossRef]
  77. Gomez-Canela, C.; Prats, E.; Pina, B.; Tauler, R. Assessment of chlorpyrifos toxic effects in zebrafish (Danio rerio) metabolism. Environ. Pollut. 2017, 220 Pt B, 1231–1243. [Google Scholar] [CrossRef]
  78. Wang, Y.; Lv, L.; Yu, Y.; Yang, G.; Xu, Z.; Wang, Q.; Cai, L. Single and joint toxic effects of five selected pesticides on the early life stages of zebrafish (Denio rerio). Chemosphere 2017, 170, 61–67. [Google Scholar] [CrossRef]
  79. Shukla, S.; Jhamtani, R.C.; Dahiya, M.S.; Agarwal, R. Oxidative injury caused by individual and combined exposure of neonicotinoid, organophosphate and herbicide in zebrafish. Toxicol. Rep. 2017, 4, 240–244. [Google Scholar] [CrossRef]
  80. Guo, D.; Wang, Y.; Qian, Y.; Chen, C.; Jiao, B.; Cai, L.; Wang, Q. Joint acute and endocrine disruptive toxicities of malathion, cypermethrin and prochloraz to embryo-larval zebrafish, Danio rerio. Chemosphere 2017, 166, 63–71. [Google Scholar] [CrossRef]
  81. D’Costa, A.H.; Shyama, S.K.; Praveen Kumar, M.K.; Fernandes, T.M. Induction of DNA damage in the peripheral blood of zebrafish (Danio rerio) by an agricultural organophosphate pesticide, monocrotophos. Int. Aquat. Res. 2018, 10, 243–251. [Google Scholar] [CrossRef] [Green Version]
  82. Korkmaz, V.; Gungordu, A.; Ozmen, M. Comparative evaluation of toxicological effects and recovery patterns in zebrafish (Danio rerio) after exposure to phosalone-based and cypermethrin-based pesticides. EcoToxicol. Environ. Saf. 2018, 160, 265–272. [Google Scholar] [CrossRef]
  83. Wang, X.; Zhou, J.; Shen, M.; Shen, J.; Zhang, X.; Jin, Y. Chlorpyrifos exposure induces lipid metabolism disorder at the physiological and transcriptomic levels in larval zebrafish. Acta Biochim. Biophys. Sin. 2019, 51, 890–899. [Google Scholar] [CrossRef]
  84. Schmitt, C.; McManus, M.; Kumar, N.; Awoyemi, O.; Crago, J. Comparative analyses of the neurobehavioral, molecular, and enzymatic effects of organophosphates on embryo-larval zebrafish (Danio rerio). Neurotoxicol. Teratol. 2019, 73, 67–75. [Google Scholar] [CrossRef]
  85. Altenhofen, S.; Nabinger, D.D.; Bitencourt, P.E.R.; Bonan, C.D. Dichlorvos alters morphology and behavior in zebrafish (Danio rerio) larvae. Environ. Pollut. 2019, 245, 1117–1123. [Google Scholar] [CrossRef]
  86. Shahjahan, M.; Rahman, M.S.; Islam, S.M.M.; Uddin, M.H.; Al-Emran, M. Increase in water temperature increases acute toxicity of sumithion causing nuclear and cellular abnormalities in peripheral erythrocytes of zebrafish Danio rerio. Environ. Sci. Pollut. Res. Int. 2019, 26, 36903–36912. [Google Scholar] [CrossRef] [PubMed]
  87. Hawkey, A.B.; Glazer, L.; Dean, C.; Wells, C.N.; Odamah, K.A.; Slotkin, T.A.; Seidler, F.J.; Levin, E.D. Adult exposure to insecticides causes persistent behavioral and neurochemical alterations in zebrafish. Neurotoxicol. Teratol. 2020, 78, 106853. [Google Scholar] [CrossRef] [PubMed]
  88. Hawkey, A.B.; Holloway, Z.; Dean, C.; Koburov, R.; Slotkin, T.A.; Seidler, F.J.; Levin, E.D. Neurobehavioral anomalies in zebrafish after sequential exposures to DDT and chlorpyrifos in adulthood: Do multiple exposures interact? Neurotoxicol. Teratol. 2021, 87, 106985. [Google Scholar] [CrossRef] [PubMed]
  89. Rahman, M.S.; Islam, S.M.M.; Haque, A.; Shahjahan, M. Toxicity of the organophosphate insecticide sumithion to embryo and larvae of zebrafish. Toxicol. Rep. 2020, 7, 317–323. [Google Scholar] [CrossRef] [PubMed]
  90. Boyda, J.; Hawkey, A.B.; Holloway, Z.R.; Trevisan, R.; Di Giulio, R.T.; Levin, E.D. The organophosphate insecticide diazinon and aging: Neurobehavioral and mitochondrial effects in zebrafish exposed as embryos or during aging. Neurotoxicol. Teratol. 2021, 87, 107011. [Google Scholar] [CrossRef] [PubMed]
  91. Bodnar, O.; Horyn, O.; Khatib, I.; Falfushynska, H. Multibiomarker assessment in zebrafish Danio rerio after the effects of malathion and chlorpyrifos. Toxicol. Environ. Health Sci. 2021, 13, 165–174. [Google Scholar] [CrossRef]
  92. Falfushynska, H.; Khatib, I.; Kasianchuk, N.; Lushchak, O.; Horyn, O.; Sokolova, I.M. Toxic effects and mechanisms of common pesticides (Roundup and chlorpyrifos) and their mixtures in a zebrafish model (Danio rerio). Sci. Total Environ. 2022, 833, 155236. [Google Scholar] [CrossRef]
  93. Povey, A.C. Gene-environmental interactions and organophosphate toxicity. Toxicology 2010, 278, 294–304. [Google Scholar] [CrossRef] [PubMed]
  94. Yang, C.C.; Deng, J.F. Intermediate syndrome following organophosphate insecticide poisoning. J. Chin. Med. Assoc. 2007, 70, 467–472. [Google Scholar] [CrossRef] [Green Version]
  95. Vacca, V.M. Organophosphate poisoning. Nursing 2012, 42, 72. [Google Scholar] [CrossRef] [PubMed]
  96. Adeyinka, A.; Muco, E.; Pierre, L. Organophosphates; StatPearls Publishing: Treasure Island, FL, USA, 2021. [Google Scholar]
  97. Peter, J.V.; Sudarsan, T.I.; Moran, J.L. Clinical features of organophosphate poisoning: A review of different classification systems and approaches. Indian J. Crit. Care Med. 2014, 18, 735–745. [Google Scholar] [CrossRef] [Green Version]
  98. Abdollahi, M.; Karami-Mohajeri, S. A comprehensive review on experimental and clinical findings in intermediate syndrome caused by organophosphate poisoning. Toxicol. Appl. Pharmacol. 2012, 258, 309–314. [Google Scholar] [CrossRef] [PubMed]
  99. Karalliedde, L.; Baker, D.; Marrs, T.C. Organophosphate-induced intermediate syndrome: Aetiology and relationships with myopathy. Toxicol. Rev. 2006, 25, 1–14. [Google Scholar] [CrossRef]
  100. Giyanwani, P.R.; Zubair, U.; Salam, O.; Zubair, Z. Respiratory failure following organophosphate poisoning: A literature review. Cureus 2017, 9, e1651. [Google Scholar] [CrossRef] [Green Version]
  101. Casida, J.E. Organophosphorus xenobiotic toxicology. Annu. Rev. Pharmacol. Toxicol. 2017, 57, 309–327. [Google Scholar] [CrossRef]
  102. Lotti, M.; Becker, C.E.; Aminoff, M.J. Organophosphate polyneuropathy: Pathogenesis and prevention. Neurology 1984, 34, 658–662. [Google Scholar] [CrossRef]
  103. Lotti, M.; Moretto, A. Organophosphate-induced delayed polyneuropathy. Toxicol. Rev. 2005, 24, 37–49. [Google Scholar] [CrossRef]
  104. Flynn, K.C. The cytoskeleton and neurite initiation. Bioarchitecture 2013, 3, 86–109. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  105. Johnson, M.K. Organophosphates and delayed neuropathy--is NTE alive and well? Toxicol. Appl. Pharmacol. 1990, 102, 385–399. [Google Scholar] [CrossRef]
  106. Richardson, R.J.; Fink, J.K.; Glynn, P.; Hufnagel, R.B.; Makhaeva, G.F.; Wijeyesakere, S.J. Neuropathy target esterase (NTE/PNPLA6) and organophosphorus compound-induced delayed neurotoxicity (OPIDN). Adv. Neurotoxicol. 2020, 4, 1–78. [Google Scholar]
  107. Peraica, M.; Capodicasa, E.; Moretto, A.; Lotti, M. Organophosphate polyneuropathy in chicks. Biochem. Pharmacol. 1993, 45, 131–135. [Google Scholar] [CrossRef]
  108. Rauh, V.A.; Garfinkel, R.; Perera, F.P.; Andrews, H.F.; Hoepner, L.; Barr, D.B.; Whitehead, R.; Tang, D.; Whyatt, R.W. Impact of prenatal chlorpyrifos exposure on neurodevelopment in the first 3 years of life among inner-city children. Pediatrics 2006, 118, e1845–e1859. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  109. Gupta, H.P.; Jha, R.R.; Ahmad, H.; Patel, D.K.; Ravi Ram, K. Xenobiotic mediated diabetogenesis: Developmental exposure to dichlorvos or atrazine leads to type 1 or type 2 diabetes in Drosophila. Free Radic. Biol. Med. 2019, 141, 461–474. [Google Scholar] [CrossRef]
  110. Furlong, C.E.; Holland, N.; Richter, R.J.; Bradman, A.; Ho, A.; Eskenazi, B. PON1 status of farmworker mothers and children as a predictor of organophosphate sensitivity. Pharm. Genom. 2006, 16, 183–190. [Google Scholar] [CrossRef]
  111. Holland, N.; Furlong, C.; Bastaki, M.; Richter, R.; Bradman, A.; Huen, K.; Beckman, K.; Eskenazi, B. Paraoxonase polymorphisms, haplotypes, and enzyme activity in Latino mothers and newborns. Environ. Health Perspect. 2006, 114, 985–991. [Google Scholar] [CrossRef] [Green Version]
  112. Sastry, B.V. Human placental cholinergic system. Biochem. Pharmacol. 1997, 53, 1577–1586. [Google Scholar] [CrossRef]
  113. Eskenazi, B.; Harley, K.; Bradman, A.; Weltzien, E.; Jewell, N.P.; Barr, D.B.; Furlong, C.E.; Holland, N.T. Association of in utero organophosphate pesticide exposure and fetal growth and length of gestation in an agricultural population. Environ. Health Perspect. 2004, 112, 1116–1124. [Google Scholar] [CrossRef] [Green Version]
  114. Whyatt, R.M.; Camann, D.; Perera, F.P.; Rauh, V.A.; Tang, D.; Kinney, P.L.; Garfinkel, R.; Andrews, H.; Hoepner, L.; Barr, D.B. Biomarkers in assessing residential insecticide exposures during pregnancy and effects on fetal growth. Toxicol. Appl. Pharmacol. 2005, 206, 246–254. [Google Scholar] [CrossRef] [PubMed]
  115. Engel, S.M.; Berkowitz, G.S.; Barr, D.B.; Teitelbaum, S.L.; Siskind, J.; Meisel, S.J.; Wetmur, J.G.; Wolff, M.S. Prenatal organophosphate metabolite and organochlorine levels and performance on the Brazelton Neonatal Behavioral Assessment Scale in a multiethnic pregnancy cohort. Am. J. Epidemiol. 2007, 165, 1397–1404. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  116. Bouchard, M.F.; Bellinger, D.C.; Wright, R.O.; Weisskopf, M.G. Attention-deficit/hyperactivity disorder and urinary metabolites of organophosphate pesticides. Pediatrics 2010, 125, e1270–e1277. [Google Scholar] [CrossRef] [Green Version]
  117. Saunders, N.R.; Liddelow, S.A.; Dziegielewska, K.M. Barrier mechanisms in the developing brain. Front. Pharmacol. 2012, 3, 46. [Google Scholar] [CrossRef] [PubMed]
  118. Bradman, A.; Barr, D.B.; Claus Henn, B.G.; Drumheller, T.; Curry, C.; Eskenazi, B. Measurement of pesticides and other toxicants in amniotic fluid as a potential biomarker of prenatal exposure: A validation study. Environ. Health Perspect. 2003, 111, 1779–1782. [Google Scholar] [CrossRef]
  119. Sultatos, L.G. Mammalian toxicology of organophosphorus pesticides. J. Toxicol. Environ. Health 1994, 43, 271–289. [Google Scholar] [CrossRef]
  120. Suwannakul, B.; Sapbamrer, R.; Wiwattanadittakul, N.; Hongsibsong, S. Organophosphate pesticide exposures in early and late pregnancy influence different aspects of infant developmental performance. Toxics 2021, 9, 99. [Google Scholar] [CrossRef]
  121. Qiao, D.; Seidler, F.J.; Slotkin, T.A. Developmental neurotoxicity of chlorpyrifos modeled in vitro: Comparative effects of metabolites and other cholinesterase inhibitors on DNA synthesis in PC12 and C6 cells. Environ. Health Perspect. 2001, 109, 909–913. [Google Scholar] [CrossRef]
  122. Kamel, F.; Hoppin, J.A. Association of pesticide exposure with neurologic dysfunction and disease. Environ. Health Perspect. 2004, 112, 950–958. [Google Scholar] [CrossRef] [Green Version]
  123. Bouchard, M.F.; Chevrier, J.; Harley, K.G.; Kogut, K.; Vedar, M.; Calderon, N.; Trujillo, C.; Johnson, C.; Bradman, A.; Barr, D.B.; et al. Prenatal exposure to organophosphate pesticides and IQ in 7-year-old children. Environ. Health Perspect. 2011, 119, 1189–1195. [Google Scholar] [CrossRef] [Green Version]
  124. Guillette, E.A.; Meza, M.M.; Aquilar, M.G.; Soto, A.D.; Garcia, I.E. An anthropological approach to the evaluation of preschool children exposed to pesticides in Mexico. Environ. Health Perspect. 1998, 106, 347–353. [Google Scholar] [CrossRef] [PubMed]
  125. Sanchez-Santed, F.; Colomina, M.T.; Herrero Hernandez, E. Organophosphate pesticide exposure and neurodegeneration. Cortex 2016, 74, 417–426. [Google Scholar] [CrossRef] [PubMed]
  126. Muir, J.L. Acetylcholine, aging, and Alzheimer’s disease. Pharmacol. Biochem. Behav. 1997, 56, 687–696. [Google Scholar] [CrossRef]
  127. Obeso, J.A. Modeling clinical features of neurodegeneration. Nat. Med. 2010, 16, 1372. [Google Scholar] [CrossRef]
  128. Priyadarshi, A.; Khuder, S.A.; Schaub, E.A.; Shrivastava, S. A meta-analysis of Parkinson’s disease and exposure to pesticides. Neurotoxicology 2000, 21, 435–440. [Google Scholar]
  129. Hancock, D.B.; Martin, E.R.; Mayhew, G.M.; Stajich, J.M.; Jewett, R.; Stacy, M.A.; Scott, B.L.; Vance, J.M.; Scott, W.K. Pesticide exposure and risk of Parkinson’s disease: A family-based case-control study. BMC Neurol. 2008, 8, 6. [Google Scholar] [CrossRef] [Green Version]
  130. Seidler, A.; Hellenbrand, W.; Robra, B.P.; Vieregge, P.; Nischan, P.; Joerg, J.; Oertel, W.H.; Ulm, G.; Schneider, E. Possible environmental, occupational, and other etiologic factors for Parkinson’s disease: A case-control study in Germany. Neurology 1996, 46, 1275–1284. [Google Scholar] [CrossRef]
  131. Manthripragada, A.D.; Costello, S.; Cockburn, M.G.; Bronstein, J.M.; Ritz, B. Paraoxonase 1, agricultural organophosphate exposure, and Parkinson disease. Epidemiology 2010, 21, 87–94. [Google Scholar] [CrossRef] [Green Version]
  132. Freire, C.; Koifman, S. Pesticide exposure and Parkinson’s disease: Epidemiological evidence of association. Neurotoxicology 2012, 33, 947–971. [Google Scholar] [CrossRef]
  133. Wang, A.; Cockburn, M.; Ly, T.T.; Bronstein, J.M.; Ritz, B. The association between ambient exposure to organophosphates and Parkinson’s disease risk. Occup. Environ. Med. 2014, 71, 275–281. [Google Scholar] [CrossRef]
  134. Diouf, J. FAO’s Director-General on How to Feed the World in 2050. Popul. Dev. Rev. 2009, 35, 837–839. [Google Scholar]
Jdb 10 00049 g001 550
Figure 1. The physiological action of acetylcholine (ACh; purple triangles) at the neuronal cell synapse, the breakdown of ACh through acetylcholinesterase (AChE; orange diamonds), and the phosphorylation of AChE through organophosphate insecticide (OP; red hexagons) exposure.
Figure 1. The physiological action of acetylcholine (ACh; purple triangles) at the neuronal cell synapse, the breakdown of ACh through acetylcholinesterase (AChE; orange diamonds), and the phosphorylation of AChE through organophosphate insecticide (OP; red hexagons) exposure.
Jdb 10 00049 g001
Jdb 10 00049 g002 550
Figure 2. The primary direct and indirect routes of organophosphate (OP) exposure on target and non-target organisms in agricultural, household and aquatic environments.
Figure 2. The primary direct and indirect routes of organophosphate (OP) exposure on target and non-target organisms in agricultural, household and aquatic environments.
Jdb 10 00049 g002
Jdb 10 00049 g003 550
Figure 3. The major consequences of OP exposure in humans.
Figure 3. The major consequences of OP exposure in humans.
Jdb 10 00049 g003
Jdb 10 00049 g004 550
Figure 4. The symptoms of organophosphate (OP) exposure at progressive time points; acute cholinergic syndrome (ACS) occurs within minutes of OP exposure, symptoms of intermediate syndrome (IMS) display at 1–4 days after OP exposure, and symptoms of organophosphate-induced delayed neuropathy (OPIDN) occur ~2–3 weeks after OP exposure.
Figure 4. The symptoms of organophosphate (OP) exposure at progressive time points; acute cholinergic syndrome (ACS) occurs within minutes of OP exposure, symptoms of intermediate syndrome (IMS) display at 1–4 days after OP exposure, and symptoms of organophosphate-induced delayed neuropathy (OPIDN) occur ~2–3 weeks after OP exposure.
Jdb 10 00049 g004
Table
Table 1. Commonly used organophosphate (OP) insecticides in agriculture and aquaculture. Shown here are approvals using the Public Chemical Registration Information System Search (PubCRIS), molecular formula and general uses.
Table 1. Commonly used organophosphate (OP) insecticides in agriculture and aquaculture. Shown here are approvals using the Public Chemical Registration Information System Search (PubCRIS), molecular formula and general uses.
Jdb 10 00049 i001Molecular Formula:
C9H10CIN2O5PS
General Uses of OP:
Used in Aquatic Farming (Atlantic Salmon) to Control Parasites.		Jdb 10 00049 i002Molecular Formula:
C10H12N3O3PS2
General Uses of OP:
Used on Orchard Fruits and Nut Crops to Control Moths.
Jdb 10 00049 i003Molecular Formula:
C9H11Cl3NO3PS
General Uses of OP:
Used broadly (crops/animals/buildings) to control roundworms, mosquitos and termites.		Jdb 10 00049 i004Molecular Formula:
C12H21N2O3PS
General Uses of OP:
Used on crops (fruits/vegetables/nuts/field crops) to control ants, fleas and cockroaches.
Jdb 10 00049 i005Molecular Formula:
C4H7Cl2O4P
General Uses of OP:
Used broadly (household/
agriculture) to control flies, caterpillars, thrips and mites.		Jdb 10 00049 i006Molecular Formula:
C9H12NO5PS
General Uses of OP:
Used broadly (public health/agriculture) to control beetles, grubs, locusts, flies, mosquitos, etc.
Jdb 10 00049 i007Molecular Formula:
C10H19O6PS2
General Uses of OP:
Used broadly (landscaping/public health/agriculture) to control mosquitos, fleas and ants.		Jdb 10 00049 i008Molecular Formula:
C8H10NO5PS
General Uses of OP:
Used in open fields (cotton, soybean, vegetable) to control boll weevils, etc.
Jdb 10 00049 i009Molecular Formula:
C10H14NO5PS
General Uses of OP:
No longer used (banned largely worldwide) due to its high toxicity.		Jdb 10 00049 i010Molecular Formula:
C11H12NO4PS2
General Uses of OP:
Used broadly (plants/animals) to control moths, mites, flies and aphids.
Jdb 10 00049 i011Molecular Formula:
C10H9Cl4O4P
General Uses of OP:
Used on animals (cattle, hogs, goats, chickens, and horses) to control flies and mites.
Table
Table 2. Studies utilising zebrafish (Danio rerio) to determine developmental and neurotoxic effects of organophosphate insecticides. dpf; days post-fertilisation. hpf; hours post-fertilisation.
Table 2. Studies utilising zebrafish (Danio rerio) to determine developmental and neurotoxic effects of organophosphate insecticides. dpf; days post-fertilisation. hpf; hours post-fertilisation.
Organophosphate(s)Dosage(s) *Gene(s) Involved **Exposure PeriodObservationsReference
Chlorpyrifos (CPF)CPF: 10 & 100 ng/mL-0–5 dpf
-
increased impaired spatial discrimination
-
both decreased (10 ng/mL) and increased (100 ng/mL) response latency in adult zebrafish
[58]
Chlorpyrifos (CPF)CPF: 100 ng/mL-0–5 dpf
-
decreased swimming activity
[59]
Malathion (MAL)MAL: 2.5 & 3 mg/L-3 hpf–5 dpf
-
increased mortality
-
decreased hatching rates
-
decreased body length
-
and decreased surface area of eye.
[60]
Malathion (MAL)MAL: 0.25, 0.5, 1, 3 & 5 mM-Adult (sexually mature)
-
decreased Adenosine Di-Phosphate (ADP) and Adenosine Tri-Phosphate (ATP) levels
[61]
Diazinon (DZN)DZN: 2000 & 3000 μg/L-8 hpf–96 hpf
-
increased heart rate
-
increased mortality
-
increased morphological irregularities (axial and tail deformities, yolk sac/heart oedema, eye irregularities
-
reduced pigmentation
-
decreased hatching rate
[62]
Chlorpyrifos (CPF)CPF: 0.25, 0.5, 0.75 & 1 mg/L-Acute: 5 dpf for 2 h
Sub-chronic: ≤1 hpf–11dpf
-
Acute—increased (≥0.25 mg/L) and decreased (≥0.75 mg/L) locomotor activity.
-
Sub-chronic—increased behavioural irregularities
[63]
Chlorpyrifos (CPF)CPF: 300, 1500 & 3000 nMRohon-Beard Development/Axonogenesis: agrin↓, cntn2↓, ntf3↓, sema3d↓3 hpf–27 hpf/51 hpf/72 hpf/4 dpf
-
increased mortality
-
increased phenotypes (axial curvature, reduced body size and reduced pigmentation)
-
decreased functioning AChE
-
increased average chevron angle (somites)
-
decreased HNK-1-positive cells
-
decreased axonogenesis-related genes
[64]
Chlorpyrifos (CPF)CPF: 0.29 μM-0–5 dpf
-
significantly increased startle response
-
increased transmitter turnover in larvae
-
decreased dopamine/serotonin levels in adults
[65]
Chlorpyrifos-oxon (CPF metabolite)CPF: 300 nM0.1 μg/L, 3 μg/L3 hpf–75 hpf
-
Defective peripheral neuron development
[66]
Dichlorvos (DCV)DCV: 20.81, 25 & 66.78 mg/L-0 hpf–96 hpf
-
decreased hatching rates
-
increased pericardial oedema
-
increased spinal irregularities
-
decreased swimming activity
[67]
Dichlorvos (DCV)

Phoxim (PHO)		DCV: N/A
PHO: 0.469, 0.513, 0.700 & 1.28 mg/L		-Adult (sexually mature)
-
DCV:
-
low toxicity (determined by LC50)
-
PHO:
-
intermediate and high levels of toxicity (determined by LC50)
[4]
Chlorpyrifos (CPF)CPF: 0.6 μM-1 ypf for 24 h
-
decreased swim rates
-
increased freeze response
-
decreased AChE in muscle
[68]
Chlorpyrifos (CPF)CPF: 0.01, 0.1 & 1 μM-6 hpf–24/48/72 hpf
-
decreased functioning AChE
-
increased TCPy (trichloro-2-pyridinol)
-
decreased functioning primary/secondary motor neurons, axonal growth and sensory neurons.
[69]
Chlorpyrifos (CPF)

Diazinon (DZN)

Parathion (PA)		CPF: 0.3, 3 & 30 μM
DZN: 10 & 30 μM
PA: 10 & 30 μM		-6 hpf–5 dpf
-
Both CPF and DZN:
-
increased mortality
-
decreased functioning AChE
-
decreased locomotor activity
-
PA:
-
increased mortality
-
decreased functioning AChE
[70]
Chlorpyrifos (CPF)CPF: 0.01 & 0.1 μM-0–7 dpf
-
decreased swim speed
-
decreased anxiety-like behaviour
-
increased behavioural irregularities
-
shortened body lengths and tail defects
[71]
Monocrotophos (MCP)MCP: 0.001 & 0.100 mg/LSexual Differentiation: cyp19a1a↑, cyp19a1b↑, foxl2↑, dmrt1↓, B-actin, ef1-a72 hpfV–16 dpf
-
increased proportion of females
-
alteration in expression of sexual differentiation genes
[72]
Chlorpyrifos (CPF)
Dichlorvos (DCV)
Diazinon (DZN)		CPF: 1, 10, 100 & 1000 μM
DCV: 100 & 1000 μM
DZN: 100 & 1000 μM		-1 hpf–5 dpf
-
CPF:
-
increased mortality
-
increased kyphosis
-
decreased spine length
-
increased spontaneous movement
-
and decreased heart rate
-
DCV:
-
increased mortality
-
increased spontaneous movement.
-
DZN:
-
increased mortality
-
increased pericardial oedema
[73]
Chlorpyrifos (CPF)CPF: 30, 100 & 300 μg/LGfap, Mbp↓, Elavl3↑, Ngn1↑, Nestin↑, Shha↑0–5 dpf
-
significantly decreased hatching rates
-
increased spine and yolk sac abnormalities
-
significantly decreased heart rates
-
significantly decreased swim speed/distance
[50]
Chlorpyrifos (CPF)CPF: 200 & 400 μg/L-2 hpfV–72 hpf
-
decreased AChE activity
-
increased AChE gene expression
-
increased glutathione (GSH) levels
[74]
Dichlorvos (DCV)DCV: 6, 19, & 32 mg/LOxidative Stress: Nrf2 (many other associated genes within the Nrf2 pathway also examined)6–12 mpf
-
decreased cholinesterase (ChE) levels in the heart/brain
-
increased myo-degeneration
-
increased testis degeneration
-
increased pancreas zymogen granule depletion
-
decreased glycogen in liver
-
altered expression of genes involved in Nrf2 signalling
[75]
Monocrotophos (MCP)MCP: 10, 20, 30, 40, 50 & 60 mg/L-4 hpf–96 hpf
-
moderate toxicity (determined by LC50)
-
decreased body length
-
decreased heart rate
-
decreased functioning AChE levels
[1]
Monocrotophos (MCP)MCP: 100 μg/LHPI Axis: Crf, Gr↓, POMC↓, P45011β, 11B-HSD2, StAR, 20B-HSD2↑, MC2R↓, TAT, PEPCKAdult (sexually mature)—21 d exposure
-
decreased whole-body cortisol
-
increased/decreased hypothalamic-pituitary-inter-renal (HPI) axis associated genes
[76]
Chlorpyrifos (CPF)CPF: 2 & 5 μM-Adult (sexually mature)
-
increased oxidative stress
-
decreased neurotransmitter metabolism
-
increased energy exhaustion
[77]
Chlorpyrifos (CPF)
Phoxim (PHO)		CPF: 0.28- 13.03 mg/L
PHO: 0.89–26.48 mg/L		-Embryo (1 hpf), larvae (72 hpf) and juvenile (1 mpf)—96 h exposure
-
CPF was determined to be more toxic than PHO (determined by LC50)
[78]
Diazinon (DZN)DZN: 6.5 mg/L-6 hpf–5 dpf
-
Moderate toxicity (determined by LC50)
[2]
Dichlorvos (DCV)DCV: 15 mg/L-Adult (sexually mature) 4–5 m—24 h exposure
-
increased levels of malondialdehyde (MDA) in liver/kidney
-
increased glutathione (GSH) in liver/kidney/brain
-
increased superoxide dismutase in liver
-
decreased levels of superoxide dismutase in brain
-
decreased catalase in kidney/brain.
[79]
Malathion (MAL)MAL: 250, 500 & 1000 μg/LHPG Axis: vtg1, vtg2, era↑, erB1, erB2, cyp19a1a, cyp19a1b↑6 dpf–10 dpf
-
low toxicity (determined by LC50)
-
upregulation of gene expression within the hypothalamic-pituitary-gonadal (HPG) axis
[80]
Chlorpyrifos (CPF)
Diazinon (DZN)		CPF: 1, 10, & 25 μM
DZN: 10 & 100 μM		-6 hpf–102 hpf
-
CPF:
-
increased mortality
-
decreased hatching rates
-
increased spinal lordosis
-
reduced activity
-
DZN:
-
increased mortality
-
increased pericardial oedema
-
decreased mitochondrial bioenergetics
[18]
Monocrotophos (MCP)MCP: 0.125, 0.625 & 1.25 uL/L 24–72 hpf
-
DNA damage observed in peripheral blood
[81]
Phosalone (PSL)PSL: 86–505 μg/L-8 wpf–96 h exposure
-
decreased functioning AChE
-
decreased carboxylesterase (CaE)
-
increased glutathione (GSH)
[82]
Chlorpyrifos (CPF)CPF: 30, 100 & 300 μg/LOxidative stress: Mn-Sod↑/↓, Cu/Zn-Sod↓, Gpx↓, Cat↓, Ucp2↓, bc12, Cox1↓ Glycolysis/Lipid: Gk↓, HK1, Pk↓, Pepckc↓, Aco↓, CPt1↓, Ppar-A↓, Acc1↓, Srebp 1a↓, Ppar-y↓, Fas↓, Fabp6, Apo↓, Dgat↓, LDLR↓, HMGCR, Fabp5Adult (sexually mature)
-
increased levels of gut mucus
-
decreased y-Protobacteria in gut
-
decreased oxidative stress genes in gut and liver
-
and decreased glycolysis and lipid metabolism-related genes
[56]
Chlorpyrifos (CPF)CPF: 30, 100 & 300 μg/LCardiovascular: Mef2c↓, Bmp4↓, VEGFR-2, JunB↑, Tbx2
Lipid: Ppar-a, Ppar-y↓, Srebp 1a, Acc1, Fas↓, Cpt1↓, Aco, Apo↓, Fabp5, Fabp6↓, Dgat↓, LDLR		2 hpf–7 dpf
-
decreased lipid accumulation in heart
-
decreased triglyceride and total cholesterol
-
increased cellular apoptosis of heart tissue
-
decreased lipid metabolism genes
[83]
Diazinon (DZN)
Dichlorvos (DCV)
Malathion (MAL)
Parathion (PA)		DZN: 0.1 & 100 μg/L
DCV: N/A
MAL: 100 μg/L
PA: 0.1 μg/L		Cholinergic: AChE↑/↓
Neurodegeneration: c-Fos, lingo-1b↑, grin-1b↓		5 hpf–5 dpf
-
DZN:
-
decreased swimming distance
-
decreased velocity
-
increase in AChE associated gene expression inhibited functioning AChe
-
increased carboxylesterase activity
-
DCV:
-
increased AChE associated genes.
-
MAL:
-
decreased swimming distance
-
decreased velocity
-
increase in AChE associated gene expression
-
increase in neurodegenerative associated gene expression
-
increased carboxylesterase activity
-
PA:
-
decrease in AChE associated gene expression
-
and decrease in neurodegenerative associated gene expression
[84]
Dichlorvos (DCV)DCV: 1, 5 & 10 mg/L-1 hpf–7 dpf
-
decreased body length
-
decreased heart rates
-
decreased surface area of eye
-
decreased escape responses
-
decreased speed
-
decreased mobile time
[85]
Sumithion (SMT)SMT: 1 mg/L-Adult (sexually mature)—96h exposure
-
increased blood glucose levels
-
increased frequency of micronucleus in erythrocytes
-
increased erythrocyte cellular and nuclear abnormalities
[86]
Chlorpyrifos (CPF)CPF: 1 & 3 μM-Adult (sexually mature) 6–8 m—2/5 w exposure
-
increased anxiety related activity (Novel Tank Diving Test)
-
increased approach response in shoaling assay
-
increased predator avoidance activity (predator avoidance assay)
[87,88]
Chlorpyrifos (CPF)
Malathion (MAL)
CPF: 0.019, 0.077, 0.31, 0.41, 1.01, 1.53 & 6.15 mg/L
MAL: 0.039, 0.16, 0.62, 2.90, 8.04, 8.54 & 12.45 mg/L		Oxidative Stress: Cat, CuSod, MnSod
Immunity: Cxcl↓, IL↑, Tnf↑/↓
Apoptosis: Cas8↑/↓, Cas9, P53, Bax
Endocrine: TRa, TRb↓, ERa, Tsh↓, Crh, cyp19a↑		1 hpf–96 hpf
-
Both CPF and MAL:
-
severe toxicity at larvae, juvenile and adult stages (compared to embryo stage)
-
significant changes in expression of immunity, apoptosis, and endocrine related genes
[57]
Sumithion (SMT)SMT: 0.1, 0.2, 0.4, 0.8 & 1.6 mg/L-Embryo/larvae
-
increased mortality in embryos and larvae
-
decreased hatching rates
-
increased morphological irregularities in embryos (damaged/underdeveloped and darkened yolk sac, broken chorion, and aberrant notochord formation)
-
increased morphological irregularities in larvae (yolk sac ulcerations/swelling and oedema, heart damage, lesion at caudal region, uninflated swim bladder, head malformation, jaw irregularities, and notochord abnormalities).
[89]
Chlorpyrifos (CPF)CPF: 1μM-Adult (sexually mature)—5 w exposure
-
decreased brain cholinesterase (ChE) activity
-
increased fleeing score.
(Hawkey, 2021)
Diazinon (DZN)DZN: 0.4, 1.25 & 4.0 μM 5–120 hpf
-
Changes in Mitochondrial oxygen utilization in the brain and testes
[90]
Malathion (MAL)
Chlorpyrifos (CPF)		MAL: 5, 50 ug/L
CPF: 0.1 & 3 ug/L		 0–14 dpf
-
increases in reactive oxygen species
-
induction of oxidative stress
[91]
Chlorpyrifos (CPF) Caspase 3↓, Bcl-2↓, Adult—8–12 months old
14 day exposure
-
Significantly elevated ROS levels
-
Elevated Reactive nitrogen species levels in high CPF dosage groups
[92]
* All dosages listed are associated with the observations summarised here, other dosages in the individual studies may have been used, but did not impact on development, behaviour or gene expression. ** ↑ and ↓ arrows indicate where there has been a significant increase or decrease in a particular gene as a response of organophosphate (OP) exposure—where no arrow shows, no significant change was noted.
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

Neylon, J.; Fuller, J.N.; van der Poel, C.; Church, J.E.; Dworkin, S. Organophosphate Insecticide Toxicity in Neural Development, Cognition, Behaviour and Degeneration: Insights from Zebrafish. J. Dev. Biol. 2022, 10, 49. https://doi.org/10.3390/jdb10040049

AMA Style

Neylon J, Fuller JN, van der Poel C, Church JE, Dworkin S. Organophosphate Insecticide Toxicity in Neural Development, Cognition, Behaviour and Degeneration: Insights from Zebrafish. Journal of Developmental Biology. 2022; 10(4):49. https://doi.org/10.3390/jdb10040049

Chicago/Turabian Style

Neylon, Jeremy, Jarrad N. Fuller, Chris van der Poel, Jarrod E. Church, and Sebastian Dworkin. 2022. "Organophosphate Insecticide Toxicity in Neural Development, Cognition, Behaviour and Degeneration: Insights from Zebrafish" Journal of Developmental Biology 10, no. 4: 49. https://doi.org/10.3390/jdb10040049

APA Style

Neylon, J., Fuller, J. N., van der Poel, C., Church, J. E., & Dworkin, S. (2022). Organophosphate Insecticide Toxicity in Neural Development, Cognition, Behaviour and Degeneration: Insights from Zebrafish. Journal of Developmental Biology, 10(4), 49. https://doi.org/10.3390/jdb10040049

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop